I think the $5 copay is part of the total in going to the generic plan. In the cost estimate, it looked like the generic substitution was $20.4 billion. It brought the cost down to $20.4 billion from $20.8 billion, so that would be a difference of $400 million. Out of that $400 million, how much is that $5...? It just sounds like a really small amount if I think about the differential between what we pay for brands versus generics.
On October 17th, 2017. See this statement in context.